Volume 9, Number 1—January 2003
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
|Outcome||HPV vaccination||No vaccination||Lifetime cases averted||No. needed to vaccinate to prevent one case|
aAssumes program that successfully administers a vaccine against high-risk HPV to the current U.S. cohort of 12-year-old girls.
bHPV, Human papillomavirus; SIL, squamous intraepithelial lesions.